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Abstract- Cardiopulmonary exercise test has been raised through recent decades as a brilliant prognostic tool 
in a wide field of diseases and clinical conditions which makes it valuable to be used in prognostic assessment 
during the current study among chronic heart failure (CHF) patients. This study recruited 71 patients with 
severe CHF who were candidates for heart transplantation. Bicycle-protocol Cardiopulmonary Exercise Test 
was done, and several parameters were measured and compared between four groups of patients based on their 
VO2/kg to show four grades of the disease from G1 to G4. Total 71 CHF subjects from 18 to 46 year of age 
enrolled in the study. Statistically significant correlations were determined between HRR, VE/VCO2, VE/VO2, 
BR and the severity of CHF. VO2max, HRR, VE/VO2, VE/VCO2, BR, and AT were the most prominent 
factors of CPET which showed their validity and reliability in terms of prognosis of CHF. It seems that 
combination of CPET and other cardiac prognostic tools like echocardiography and measurement of the 
pressure in cardiac chambers can improve the prognosis in CHF. 
© 2018 Tehran University of Medical Sciences. All rights reserved.  
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Introduction 
 
Heart failure is a critical condition disregarding its 
hereditary or acquisitive base which involves 6-10% of 
individuals over 65 years of age. Chronic heart failure 
(CHF) is a serious problem in 5.8 and 15 million people 
in the US and Europe, respectively (1,2). In Iran, CHF is 
hitting the record of 3500 in 100,000 of the population in 
the near future (3,4). The most prominent causes of CHF 
in the industrial world are undoubtedly cardiovascular 
diseases (CAD) and arterial hypertension. Through recent 
decades, Cardiopulmonary Exercise Test (CPET) has 
been added to conventional studies for CHF like 
echocardiography, exercise test, electrocardiography and 
serum biomarkers. This test is now one of the most 
important strategies of diagnosis and prognosis 
determination and consequently a valid tool to make 
plans to manage CHF in Europe and the United States 
(5,6). 
Heart transplantation is a final reliable way to manage 
CHF which has been also highly focused in Iran through 
recent decades (7). Heart transplantation is thought as a 
probable effective solution against conventional 
conservative therapies, nowadays (8). CPET has fixed its 
place between many other prognostic and predictive tools 
to achieve the fact that people with advanced CHF 
(maximum O2 consumption >10 ml/Kg/min) have greater 
chance of survival. CPET shows that heart transplantation 
in the named group is obviously more successful than 
conservative therapies (7). 
This is worth thinking that pomp incapacitation is not 
always the main cause of troubles in CHF, while any 
problems in muscular and/or peripheral circulation, 
individual ways of breathing during exercise, and also 
CPET in advanced heart failure 
536    Acta Medica Iranica, Vol. 56, No. 8 (2018) 
anthropometric measures in addition to muscle mass and 
type of muscular fibers are very important in CPET 
interpretation. 
 
AT(VAT)  
Ventilatory anaerobic threshold or anaerobic 
threshold (AT) in brief, is a point which the aerobic 
metabolism fails to consume more oxygen at as the main 
source of fuel shifting to anaerobic metabolism to 
produce local lactate in muscles (9-11). AT is calculated 
by analysis produced CO2 (VCO2) and consumed O2 
(VO2) through their exchanges in the mouth. The v-slop 
method shows the fact that VO2/VCO2 slope is less than 
1 in aerobic but rises in anaerobic ventilation to more than 
1. Increased CO2 production after AT is the main cause 
of increased ventilation to fix the linear correlation 
between minute ventilation (VE) and VCO2 and keep CO2 
end-tidal pressure (PETCO2) still (12,13). AT is almost 
always considered as the ratio of VO2/VO2max which is 
supposed to be 40-60% (14). This ratio would grow even 
up to 80% in trained athletes (15). All the pathologic 
conditions resulted from CHF which disturb the chain of 
O2 transportation obviously lower the AT even by 40%. 
(16). Most of the time, there is an undetermined AT in 
CPET due to limited exercise capacity in addition to 
fluctuated VE in the majority of CHF subjects. 
VO2max or in other words “aerobic power” is defined 
as the maximum energy which is available during aerobic 
metabolism. Minute ventilation (VE )and VO2 max are 
usually affected by cardiac output, arterial O2 content, 
distribution of cardiac output in the muscles, the ability 
of muscles to consume O2, and finally some features in 
the central nervous system (17). VO2max, in other words, 
is the point that VO2 fails to rise in spite of increasing load 
of exercise (18). Age, sex, BMI, ordinary daily activity 
and genetic features usually affect VO2max (19,20). 
VO2max starts to reduce 10% on average for every 10 
years of age after 30. This is mainly because of decreased 
maximum heart rate, stroke volume, musculoskeletal 
blood flow and the capacity of aerobic metabolism in 
skeletal muscles (21). Decreased capacity of aerobic 
exercise is obviously the key point of CHF 
pathophysiology which is led by changes in peripheral 
organs such as skeletal muscles, endothelium, local blood 
flow, and cardiovascular reflex control systems in 
addition to central organs like lungs, heart, and arterial 
blood hemoglobin content (22,23). 
VE, simply as the amount of the air which individuals 
take O2 from, is always increased when compared with 
healthy people at the same age. This means the fact that 
CHF patients lose their competence in taking enough O2 
from the air (24). 
This study was designed and conducted based on 
pretesting cases of heart transplantation to separate CHF 
cases from other situations like deconditioning which are 
usually treated via rehabilitation and training instead of 
invasive ways like transplantation.  
Materials and Methods 
 
Through a cross-sectional study, we recruited patients 
who referred to CPET department at a tertiary hospital in 
Tehran before heart transplantation to recheck their 
indications for the operation.  Patients over 14 years of 
age enrolled the study if were metabolically stable and 
cooperated the test. Individuals who did not meet 
maximum effort criteria (RER<1.15; HR peak <85% of 
the predicted; Borg score <8.10) or had respiratory 
disease, orthopedic issues or aortic valve stenosis quitted 
the study. After giving their informed consent, the 
participants were checked for demographics, 
comorbidities, current medications, and 
echocardiography and spirometry.  
 
Bicycle CPET protocols  
For CHF subjects, both treadmill and bicycle CPET 
protocols are suitable among which the second protocol 
was used by the current study. The starting load is usually 
20-25 W increasing 15-25 W every two minutes to 
achieve the maximum load of exercise. Electronic 
ergometer, which was utilized by this study, could 
estimate the starting load and establish a 10 W/min-ramp-
protocol. Bicycle CPET seems to have obviously less 
false results than the treadmill because of less noise in 
addition to lower metabolic expenditure for patients. 
Furthermore, the bicycle is not as expensive as treadmill 
and needs smaller space. 
 
RER  
The ratio of VCO2/ VO2 is named as respiratory 
exchange ratio (RER) which is naturally an index of 
metabolism in body tissues.  
 
CPET contraindications  
There is a wide range of medical conditions in this 
regard that the most serious ones are myocardial 
ischemia, unstable angina, syncope, acute endocarditis, 
and uncontrolled asthma. 
 
CPET ending indications  
Chest pain, ischemic ECG pattern, heart blocks, 
hypertension (>250 mm Hg systolic; >120 mm Hg 
diastolic), >20 mm Hg fall in systolic blood pressure, 
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severe desaturation (Spo2≤80%) along with symptoms 
and signs of hypoxemia, sudden pallor, dizziness and 
finally mental confusion is the most known indications of 
putting the test an end. In these cases, the patient was 
monitored for recovery at rest to make sure of stable and 
safe condition. 
CPET procedure  
After selecting a suitable mask the patient placed on a 
medical electronically braked bicycle and started the test 
with 10 W/min-ramp protocol with 10-15 W based on the 
patient's ability. For three minutes the patient sat on the 
bicycle for a short relax before starting to steal for 2 
minutes without load. Before starting the test, the patient 
was asked to breathe fast and deep for 12-15 seconds to 
calculate MVV. Throughout the test, exhaled gases were 
measured "breath by breath" through exhalation airflow 
analysis. At the same time, heart rate, O2 saturation, and 
electrocardiography were monitored and recorded. 
All the participants were divided into four groups 
regarding their VO2/kg to separate different CHF severity 
as follows: 
Group 1: VO2/kg>20 
Group 2: 16< VO2/kg<19.99 
Group3: 10< VO2/kg<15.99 
Group4: VO2/kg≤9.99 
Group1 (G1) had the best condition with less severity 
of CHF while G4 had the most severe disease regarding 
the “West” method. 
 
Statistics  
This study recruited patients considering simple 
sample selection, and no randomization was done. All 
collected data were checked for normal distribution, 
firstly. There was no need to use nonparametric tests. 
Central tendency indices were reported for quantitative 
data by using means, modes, medians, and standard 
deviations. The confidence interval (CI) was defined as 
95% along with a type 1 error (α) of 0.05 and the 
significance of 0.05. Chi-square test was used when 
qualitative data were compared while t-test was used for 
quantitative comparative issues. 
 
Ethics  
The current study considered the "Helsinki 
Statement" in terms of ethical issues. All the patients were 
free to participate in the study regarding the inclusion and 
exclusion criteria with no facilitation or advantage while 
nobody was limited to continue getting medical supports 
due to regret to participate. All the participants were able 
to quit the study with no penalty or permission whenever 
they wished.  
 
Results 
 
Total 71 patients including 58 males (81.6%) and 13 
females (18.4%) enrolled the current study regarding the 
inclusion and exclusion criteria. The mean age±SD was 
32.8±12.12 years containing 18-46-year-old patients. The 
patients were divided into four groups based on their 
VO2/kg as defined before in methods. Table 1 shows the 
frequency and percentage of the participants in each 
group. 
 
 
Table 1. Grouping of the participants regarding their VO2/kg. AT and gender information are also 
provided 
Grade 
Cases 
(%) 
Sex /kg2VO 
AT(mean±SD) 
M F Mean±SD Median Mode min Max 
G1 7 (9.9) 6 1 23.47±3.22 22.1 20.5 20.5 28.8 48.86±21.46 
G2 10 (14.1) 7 3 17.9±1.2 17.8 18.9 16.2 19.5 37.2±12.27 
G3 37 (52.1) 28 9 12.62±1.53 12.5 12.5 10 15.7 28.11±9.21 
G4 17 (23.9) 13 4 7.86±1.6 8.1 6.1 4.6 9.8 17.06±5.85 
 
 
There was no relationship between sex and severity of 
CHF among the subjects (P=0.528). On the contrary, 
there was a strong correlation between AT and VO2/kg 
(P=0.001) which is summarized in table 2 that shows the 
most AT (48.86) in group 1 as expected. The most 
significant difference was found between G1 and G4 in 
terms of AT although G2 had no prominent difference 
with G1 and G3 (P=0.92 and P=0.133, respectively). 
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Table 2. PostHoc table for the Tukey test for AT in groups of participants. The most predominant 
differences were seen between G4, G2, and G1 
Tukey HSD 
vo2/kg vo2/kg 
Mean 
Difference 
Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
G4 
G3 -11.049* 3.145 .004 -19.34 -2.76 
G2 -20.141* 4.278 .000 -31.41 -8.87 
G1 -31.798* 4.821 .000 -44.50 -19.10 
G3 
G4 11.049* 3.145 .004 2.76 19.34 
G2 -9.092 3.826 .092 -19.17 .99 
G1 -20.749* 4.425 .000 -32.41 -9.09 
G2 
G4 20.141* 4.278 .000 8.87 31.41 
G3 9.092 3.826 .092 -.99 19.17 
G1 -11.657 5.290 .133 -25.60 2.28 
G1 
G4 31.798* 4.821 .000 19.10 44.50 
G3 20.749* 4.425 .000 9.09 32.41 
G2 11.657 5.290 .133 -2.28 25.60 
*. The mean difference is significant at the 0.05 level 
 
 
The mean±SD for VO2/kg was 13.292±4.87 lit/kg for 
all 71 subjects with the range of 4.6-28.8 lit/kg. Table 3 
shows central tendencies and the range of the most 
important parameters this study measured. Heart rate 
reserve (HRR) was significantly higher in group 4 
(63.53). ANOVA found an obvious direct significant 
correlation between HRR and the severity of CHF which 
grew from G1 to G4 (P=0.019). 
 
Table 3. Central tendency indices of CPET for some key parameters regarding 
patients’ gender 
Parameter Sex Mean Std. Deviation Std. Error Mean 
LoadMax Male 40.80 17.549 2.588 
Female 40.09 22.385 6.749 
HRmax Male 71.63 11.880 1.752 
Female 71.27 11.306 3.409 
HRR Male 51.04 22.443 3.309 
Female 53.00 21.753 6.559 
o2pulse% Male 56.61 19.840 2.925 
Female 57.09 13.502 4.071 
VO2max Male 1.0654 .40310 .05943 
Female .6864 .20190 .06088 
AT Male 29.83 14.879 2.194 
Female 28.55 12.275 3.701 
VE.VCO2 Male 35.552 8.3881 1.2368 
Female 37.127 6.2102 1.8724 
VElitr Male 45.57 12.927 1.906 
Female 32.00 9.241 2.786 
BRmax Male 82.865 24.9136 3.6733 
Female 67.509 24.0766 7.2594 
 
 
Figure 1 illustrates the linear correlation between 
HRR and severity of the disease in which a steep slope is 
seen between the groups in this regard except between G2 
and G3. 
Concerning VE/VO2 and VE/VCO2, a significant 
correlation was seen between the groups of participants 
to show obviously higher amounts in group 4 (P<0.001) 
as seen in figure 2. Groups 1 and 3 had no statistical 
difference in terms of VE/VO2 differential (P=0.597). 
VE/VCO2 had the most prominent difference between 
G1 and G4 as expected (13.71) (P<0.001). Although G2 
had no difference with G1 and G3 (P<0.551 and 0.539, 
respectively) G4 differed with other groups in this matter. 
The relevant negative coefficients demonstrate the 
indirect correlation of VE/VO2 and VE/VCO2 with 
VO2/kg (Figure 3). 
A parameter named VE% is defined as the ratio of 
VE/MVV multiplication by 100 which is actually the rate 
of O2 consumption and aerobic exercise against the 
predicted rate for each participant. ANOVA showed a 
significant relationship between the named parameter 
(VE%) and the severity of CHF, directly (P<0.001). when 
compared using the "Tukey" test, G2 and G4 had the most 
prominent correlation with VE%, and G1 failed to show 
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any valuable correlation as illustrated by figure 4. 
Breathing reserve (BR: MVV-VEmax) increased 
from G1 to G4 to show indirect significant linear 
correlation with VO2/kg. The highest amount of it was 
141.3 in G3 whilst its least amount of 22.6 in the same 
group (P=0.011). 
For VO2 max, G1 and G2 had higher levels than the 
other which is reasonable since the current study divided 
the participants based on VO2/kg. Post Hoc test endorsed 
the mentioned indirect relationship with the groups 
(P<0.001), and the means plot is seen in figure 5. 
 
 
Figure 1. The linear correlation between HRR and CHF severity in four groups of the study. Group 4 had the least amounts of VO2/kg. The 
diagram illustrates the indirect strong correlation between HRR and VO2/kg 
 
 
Figure 2. Correlation diagrams of VO2/kg with VE/VO2 (above) and VE/VCO2 (below). Indirect strong correlation was obviously found 
CPET in advanced heart failure 
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Figure 3. The diagram shows direct correlation between the VE% and VO2/kg but groups 2 and 1 had a faded correlation of the named items as 
can be seen which may be resulted due to low sample size in group 1 
 
 
Figure 4. A regression test showed indirect correlation between BRmax and VO2/kg. The means plot is seen on the right side. The relationship is 
faded between group 2 and 1 mainly due to the low number of participants in the latter 
 
 
Figure 5. As expected, VO2max had a very strong linear correlation with VO2/kg of the participants 
 
 
Discussion 
 
The main aim of the current study was the assessment 
of key parameters of Ergospirometry in CHF patients 
who were candidate for heart transportation, and it found 
some valuable correlation in terms of the mentioned 
parameters and the severity of the disease. 
As can be seen in table 1, the groups had different 
numbers of patients which are usually expected in cross-
sectional clinical studies, and it had no effect on the 
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results due to the power of the correlation except some 
issues for the group 1 because of containing only 7 
subjects. The oldest participant was in his/her 40's which 
is very lower age than many other studies. This may be 
mainly because of less referral to CPET in advanced age 
by Iranian physicians based on musculoskeletal 
limitations or higher risk of comorbidities which make 
exercise test more difficult (25). The number of patients 
to be studied in the current research was enough 
comparing with many other works to get an acceptable 
power of the study. (26-29). 
It was expected to witness a direct correlation between 
AT and VO2/kg in CPET and the current study 
determined the highly strong result in this regard between 
G1 and G4 despite non-significant differences in G1 to 
G3. 
The mean of VO2 was just more than 13 ml/kg/min 
which was expectedly lower than individuals with heart 
failure with preserved ejection fraction (HFPEF) in a 
study conducted by Garcia et al., in 2015 who reported 
VO2 mean of 17 ml/kg/min (25). HFPEF patients have the 
naturally better condition than the patients we studied, but 
they probably have growth in hospitalization rate up to 
32% for each 10% fall in peak VO2 (27). However, the 
current study did not follow up patients, and there is 
nothing to conclude or compare about outcome or 
prognosis of CHF among our participants. 
Grazzi et al., working on a population-based study in 
2017, determined that the ratio of actual peak 
VO2/predicted VO2 correlated indirectly with the survival 
rate in 1400 participants. (30) 
The current study was not trying to assess the effects 
of comorbidities on CPET results; so, all the patients with 
BMI>30, anemia, lung or kidney disease, diabetes, 
malignancies, depression, psychological disorders and 
musculoskeletal problems even knee arthrosis and 
rheumatoid arthritis were excluded (31). 
We also disclosed a rather strong indirect correlation 
between HRR and VO2 /kg among our CHF patients, 
especially between G1 and G2; likely, between G3 and 
G4. Groups 2 and 3 had a weaker correlation and G1, 
despite the limited number of participants, had a good 
prominent result in this regard. 
In a study by Czubaszewski et al., in 2017, 132 men 
with heart failure were followed up for 2 years using 
CPET to disclose that HR indices, although not of the 
quality of VE/VO2, are valuable in terms of the 
determination of prognosis in CHF patients. These 
parameters are obviously weaker than respiratory 
parameters in this regard but are key prognostic 
determinants, especially in the absence of the relevant 
facilities of exercise test in distant areas (29). They 
concluded that individuals with weak prognosis of HF 
had LVEF <45%, lower HR max (122/min), lower 
chronotropic index (CHI), lower peak VO2 and higher 
VE/VCO2 at AT which correlated indirectly with VO2/kg 
through the current study to show the most severity of 
disease by its higher amounts as also shown before (32). 
Increased ventilatory response to exercise metabolic 
demand, named VE/ VCO2, as Rocha et al., expressed in 
2017, is a very common finding in COPD subjects with 
coincident heart failure. A destructive disease like COPD 
could increase the respiratory effort to reach an accepted 
supply compared to healthy lungs due to a V/Q mismatch 
which wastes patient’s attempts to access enough O2 
(28). 
At weaker level, VE/VO2 may help in terms of 
determining prognosis and life quality and other kinds of 
approach to HF patients. The current study showed a 
significant difference between G4 and other groups of 
participants to endorse the efficacy of VE/VO2 as a key 
parameter of CPET in HF subjects. 
VE% (VE/MVV×100) correlated indirectly with the 
severity of CHF in our participants, especially in group 4; 
but there was no previous work, as far as our knowledge, 
to compare the findings within this matter. 
In healthy individuals, BR is 10-40% of MVV which 
could be around 11 lit/min in raw form. Lower amounts 
of BR figures a respiratory and ventilatory problem 
resulted from primary lung disease and its least amounts 
occur in obstructive lung diseases. On the contrary, 
higher amount of BR is an index of cardiovascular 
problems (5). Our study obtained higher measures of BR 
in more severe cases of heart failure. Toma et al. preferred 
to express that in heart failure, BR could be usually in the 
normal range just to rule out respiratory cases (5). 
Concerning the pathophysiology of O2 consumption at 
the tissue level, two things are important including 
capillary density in tissues and especially muscles, 
secondly, mitochondrial density in muscular 
ultrastructure. These factors absolutely help obtain much 
more energy from O2 at the best way of metabolism (33). 
VO2 max was the last parameter to report which 
differed from group to group despite low number of cases 
in G1 and G2. Hussain et al., showed in Pakistan that VO2 
max indirectly correlated with age of CHF patients who 
had LVEF 10-35% but was directly in a relationship with 
CPET duration, blood hemoglobin level and LVEF (34). 
Unlikely, Malek-Mohammad et al., found no correlation 
between VO2 max and age, height, weight, BMI and 
LVEF in 2012 among 22 cases of severe heart failure with 
LVEF<30%. (35) 
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Unjustified dyspnea is indeed a common condition 
needing several diagnostic techniques to determine and 
manage. Ergospirometry is only one of the wide ranges 
of those diagnostic ways in recent decades (36). 
Ergospirometry along with myocardial perfusion imaging 
(MPI) has shown that patients with normal MPI and 
abnormal CPET results should be focused for respiratory 
issues instead of cardiovascular ones in a study in 2017 
(37). However, CPET can brilliantly put patients in 
physical exercise situation to manifest their hidden 
symptoms which are important to diagnose the 
predisposing disease to dyspnea (32). 
 
Study limitations  
Heart transplantation is not actually a common 
procedure at least in Iran, and this was mainly why we 
were limited to establish strict inclusion criteria to keep 
rather suitable sample size.  
Due to small sample size, there was no ability to 
dividing the participants based on age, career, and 
etiology of HF pushing patients to transplantation, risk 
factors of HF, and other important factors. Categorization 
could lessen the number of participants in each group to 
make analysis much difficult. 
However, using statistical tools, the study tried to 
assess the effects of some crucial factors disregarding 
other probable confounding factors on CPET parameters. 
Finally, we decided to categorize the participants based 
on the severity of HF as well as VO2/Kg in order to get 
the most reliable output.   
The current study found prominent correlations of 
CPET parameters and CHF severity to be useful in 
approach and prognosis determination for CHF despite 
limitations. It seems to be more useful to involve many 
other factors including the cause of test termination and 
some comorbidities as well as echocardiography findings 
via case-control or clinical trial studies to find much more 
interesting information among wider range of patients. 
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